To Explore the Effectiveness of Jing-Si Herbal Tea Against Non-alcoholic Fatty Liver Disease
1 other identifier
interventional
108
1 country
1
Brief Summary
The aim of this study is to explore the effectiveness of Jing-Si Herbal Tea on improving the Non-alcoholic fatty liver disease patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 3, 2022
CompletedFirst Submitted
Initial submission to the registry
April 26, 2023
CompletedFirst Posted
Study publicly available on registry
May 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedSeptember 9, 2025
September 1, 2025
2.7 years
April 26, 2023
September 2, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
Assessing the changes from baseline blood glucose at 24 week
Collect the data of blood glucose from blood test
24 week
Assessing the changes from baseline GOT (Glutamic Oxaloacetic Transaminase) at 24 week
Collect the data of GOT from blood test
24 week
Assessing the changes from baseline GPT (Glutamic Pyruvic Transaminase) at 24 week
Collect the data of GPT from blood test
24 week
Assessing the changes from baseline total cholesterol at 24 week
Collect the data of total cholesterol from blood test
24 week
Assessing the changes from baseline triglycerides at 24 week
Collect the data of triglycerides from blood test
24 week
Assessing the changes from baseline HDL-C at 24 week
Collect the data of HDL-C from blood test
24 week
Assessing the changes from baseline LDL-C at 24 week
Collect the data of LDL-C from blood test
24 weekk
Assessing the changes from baseline NAFLD activity at 24 week
Scoring the level of NAFLD activity
24 week
Assessing the changes from baseline BMI at 24 week
Collect the body height and body weight, weight and height will be combined to report BMI in kg/m\^2
24 week
Study Arms (2)
Jing-Si Herbal Tea group
EXPERIMENTALEach patient will receive Jing-Si Herbal Tea two times (after breakfast and lunch) in a day for 24 weeks.
Placebo group
PLACEBO COMPARATOREach patient will receive placebo two times (after breakfast and lunch) in a day for 24 weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Sign the Informed consent
- Age between 20-70
- Diagnosis for moderated NAFLD
- Liver disease without hepatic decompensation
- HbA1c \< = 8.0 %
You may not qualify if:
- Do not sign the Informed consent
- Other related liver diseases will affect the study which evaluated by physicians
- Women of potential pregnancy or pregnant women
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Taichung Tzu Chi Hospital
Taichung, Taiwan, 42743, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 26, 2023
First Posted
May 15, 2023
Study Start
May 3, 2022
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
September 9, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share